In 1913, journalist Samuel Hopkins Adams published “What Can We Do About Cancer? The Most Vital and Insistent Question in the Medical World,” hereafter “What Can We Do About Cancer,” in Ladies’ Home Journal. Cancer is a disease that is the result of abnormal cell division in different parts of the body, such as the breasts or the cervix. During that time, many women did not discuss or disclose early symptoms of reproductive cancers, such as breast lumps and abnormal vaginal discharge, out of shame or disgust. Thus, people often considered cancer to be a taboo topic. “What Can We Do About Cancer?” provides a representation of what people in the early 1900s thought to be the early warning signs of cancer in women. Although, as of 2021, researchers have made advancements that have increased the scientific understanding of cancer and how it develops, Adams’ article provided women in the US during the 1900s with recommendations on early methods of cancer detection.
In 2017, Angiolo Gadducci, Silvestro Carinelli, and Giovanni Aletti published, "Neuroendocrine Tumor of the Uterine Cervix: A Therapeutic Challenge for Gynecologic Oncologists," hereafter, "Neuroendocrine Tumor" in the journal, Gynecologic Oncology. The authors conducted a systematic review of existing literature that documented the symptoms, diagnosis, staging, treatment, and outcomes of women diagnosed with neuroendocrine tumors, or cervical NETs, which are tumors with cells similar to cells from both the hormonal and the nervous system. Based on high mortality rates and the rarity of cervical NET diagnoses, the authors conclude that cervical NETs present a challenge for physicians in terms of devising novel ideas for treatment. By compiling the treatment methods and resulting outcomes of different studies, the authors presented evidence that there is a need for new forms of treatment to reduce the number of women dying from cervical NETs each year.
In 2002, the Writing Group for the Women's Health Initiative Investigators published the article Risks and Benefits of Estrogen Plus Progestin in Healthy, Postmenopausal Women: Principal Results from the Women's Health Initiative Randomized Controlled Trial in The Journal of the American Medical Association. In the article, the authors report on the Women's Health Initiative, which was a study initiated by the National Institutes of Health to determine the effects of hormone therapy in postmenopausal women, or women whose menstrual cycles have stopped, from the ages of fifty to seventy-nine. The researchers attempted to determine if a link existed between a common type of hormone therapy, a combination of estrogen and progestin, and prevalent diseases in postmenopausal women, including cardiovascular disease and cancer. As reported by the authors in their article, the researchers discontinued the study after five years when they found that there were many risks associated with the use of estrogen plus progestin hormone therapy, including increased risks of breast cancer and heart diseases.
Between 1925 and 1961, a Roman Catholic order of nuns called the Bon Secours Sisters operated the Bon Secours Mother and Baby Home, or the Home, an institution where unmarried pregnant women gave birth in Tuam, Ireland. Pregnant women who delivered their infants at the Home were required to work at the Home for no less than one year without pay. The Irish government and the Catholic Church endorsed the Mother and Baby Home as a means to limit the number of children born out of wedlock by discouraging women from getting pregnant before marriage. During the Home’s thirty-six years of operation, the nuns reported that almost 800 children died in their care. In 2015, researchers discovered a tomb of 796 infant and child skeletons in a septic tank underneath where the Home once stood. The acceptance and use of Mother and Baby Homes revealed the way Ireland treated pregnant women in the twentieth century.
In the late-twentieth century in the United States, Catherine DeAngelis was a pediatric physician, researcher, and editor of multiple medical journals. During her time with the Journal of the American Medical Association, DeAngelis became the journal’s first female editor. At Johns Hopkins University in Baltimore, Maryland, she studied how physician-nurse interactions affected patient care, how immunizations and adolescent pregnancy affected children, and how medications affected men and women differently. She also worked to reduce gender inequality in the practice of medicine by publishing articles that addressed the pay gap between men and women at Johns Hopkins. Throughout her career, DeAngelis advocated for equality between men and women in the medical field and supported equal treatment of women as patients and as practitioners of medicine. By doing so, she helped women become more central participants in medicine and therefore helped increase the focus on women's health in medicine.
Polycystic ovarian syndrome or PCOS is one of the most common reproductive conditions in women, and its symptoms include cystic ovaries, menstrual irregularities, and elevated androgen or male sex hormone levels. During the 1930s, Irving Freiler Stein and Michael Leventhal identified the syndrome and its symptoms. Women who experience symptoms of PCOS may also experience secondary symptoms, including infertility and diabetes. Though estimates vary and the causes of the syndrome are not clear as of 2017, PCOS affects approximately ten percent of women of reproductive age. Women who suspect they have symptoms of PCOS should see a doctor, as early treatment may help prevent long-term implications such as infertility, diabetes, and some types of cancers.
During the twentieth century in the United States, Bernadine Patricia Healy was a cardiologist who served as the first female director of the National Institutes of Health or NIH and the president of both the American Heart Association and the American Red Cross. Healy conducted research on the different manifestations of heart attacks in women compared to men. At the time, many physicians underdiagnosed and mistreated coronary heart disease in women. Healy's research illustrated how coronary heart disease affected women. Healy was also the deputy science advisor to the United States president Ronald Reagan, and during her time at the NIH, she founded the Women's Health Initiative. That initiative was a $625 million research study that aimed to determine how hormones affected diseases specific to postmenopausal women. Through her research and leadership positions, Healy helped improve women's healthcare in the US and helped expand the resources available for research into women's health.
Ephraim McDowell was an US abdominal surgeon who in 1809 performed one of the first successful ovarian surgeries. McDowell conducted his medical practice in Danville, Kentucky, where he used novel methods of ovariotomy to remove a twenty-two and a half pound ovarian tumor from his patient, Jane Crawford. At the time, surgeons performed ovariotomies by making an incision into each patient’s ovary to remove a mass. However, their patients often died from infection or blood loss. McDowell’s methods included making an incision into the abdominal muscles, draining the abdomen of blood, and using adhesives with sutures to close the wound. McDowell performed one of the first invasive abdominal surgeries in which the patient survived, and his surgical techniques established the potential safety and efficacy of ovarian and abdominal surgery in the 1800s.
Between 1958 and 1962, physicians Olive W. Smith, George V. Smith, and Robert W. Kistner performed experiments that demonstrated the effects of the drugs MER-25 and clomiphene citrate on the female human body. MER-25 and clomiphene citrate are drugs that affect estrogen production in women. At the time of the experiment, researchers did not know which organ or organs the drugs affected, the ovaries and/or the anterior pituitary gland. To determine that, the physicians reviewed nine of their own previous studies in women in which they measured the urinary output of hormones after the administration of either drug. Based on their examination the researchers concluded that MER-25 appeared to influence the anterior pituitary gland in the brain to produce a response in the ovaries and that clomiphene citrate appeared to act on the ovaries. Their results provided early evidence about the mechanisms of both drugs. Later, clomiphene citrate became a common fertility drug.
In the nineteenth century, Elizabeth Blackwell was a women’s healthcare reformer and the first woman to receive her medical degree in the United States. She practiced medicine as a primary care physician in both the United States and the United Kingdom. Blackwell graduated medical school from Geneva Medical College in Geneva, New York, where she was the first woman to receive a medical degree in the US. Throughout her career, Blackwell focused on her patients’ rights to access healthcare and education pertaining to healthcare, particularly the rights of women and children, whom she treated in a hospital she cofounded. Blackwell influenced the medical care during the Civil War in the United States by training nurses to treat soldiers injured in battle. In her lifetime, Blackwell educated women on their health and careers as healthcare providers, and as the first woman to receive a medical degree, made it easier for other women to become physicians in the United States.